Issue 50, 2017
From the journal:

Chemical Communications

Selectively switching on europium emission in drug site one of human serum albumin†

Sergey Shuvaev,a   Robert Pala  and  David Parker ORCID logo *a  

* Corresponding authors

a Department of Chemistry, Durham University, South Road, Durham DH1 3LE, UK
E-mail: david.parker@dur.ac.uk

Abstract

A luminescent europium probe has been discovered that binds selectively to drug-site I in human serum albumin, signalled by a ‘switching on’ of europium emission, and accompanied by strong induced circularly polarised luminescence.

Graphical abstract: Selectively switching on europium emission in drug site one of human serum albumin

About
Cited by
Related
Download options Please wait...

Supplementary files

Article information

DOI
https://doi.org/10.1039/C7CC03071A
Article type
Communication
Submitted
21 ኤፕሪ 2017
Accepted
02 ጁን 2017
First published
02 ጁን 2017

Chem. Commun., 2017,53, 6724-6727

Permissions

Request permissions

Selectively switching on europium emission in drug site one of human serum albumin

S. Shuvaev, R. Pal and D. Parker, Chem. Commun., 2017, 53, 6724 DOI: 10.1039/C7CC03071A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements